n-vinyl-2-pyrrolidinone has been researched along with Atherogenesis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z; Hu, D; Jiang, J; Jiang, L; Lian, M; Liu, X; Peng, H; Wang, J; Wang, N; Zhang, C; Zhao, M | 1 |
1 other study(ies) available for n-vinyl-2-pyrrolidinone and Atherogenesis
| Article | Year |
|---|---|
Sonodynamic therapy in atherosclerosis by curcumin nanosuspensions: Preparation design, efficacy evaluation, and mechanisms analysis.
Topics: Administration, Oral; Animals; Apoptosis; Atherosclerosis; Biological Availability; Cholesterol; Combined Modality Therapy; Curcumin; Disease Models, Animal; Drug Delivery Systems; Humans; Lipoproteins, LDL; Male; Membrane Potential, Mitochondrial; Mice; Mice, Knockout, ApoE; Nanoparticles; Particle Size; Pharmaceutical Vehicles; Povidone; RAW 264.7 Cells; Reactive Oxygen Species; Sodium Dodecyl Sulfate; Theranostic Nanomedicine; Ultrasonic Therapy | 2020 |